{
    "clinical_study": {
        "@rank": "6372", 
        "arm_group": [
            {
                "arm_group_label": "Laminaria group", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in this group will have cervical preparation with laminaria MedGyn Products, Inc. USA overnight the day before the abortion"
            }, 
            {
                "arm_group_label": "Misoprostol group", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in this group will have cervical preparation with vaginal Misoprostol 600 mcg overnight the day before the abortion"
            }
        ], 
        "brief_summary": {
            "textblock": "This study compares the effectiveness of cervical preparation before second trimester\n      abortion using laminaria versus vaginal Misoprostol.\n\n      The investigators hypothesize that medical preparation of the cervix with vaginal\n      Misoprostol is superior to mechanical preparation using laminaria.\n\n      The investigators believe that medical preparation makes the procedure easier to perform,\n      equally safe, without addition of pain or discomfort."
        }, 
        "brief_title": "Comparison of Laminaria and Misoprostol for Cervical Preparation Before Second Trimester Surgical Abortion", 
        "completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "condition": "Induced; Abortion, Nonmedical", 
        "detailed_description": {
            "textblock": "This is a prospective randomized study.\n\n      The aim of the study is to compare preparation of the cervix before surgical abortion with\n      laminaria and misoprostol.\n\n      Primary outcome measures will include:\n\n      Initial cervical opening and the need for further dilatation at the procedure Procedure\n      duration\n\n      Difficulty score performing the abortion\n\n      Complications during and after the procedure\n\n      Assessment of pain, using VAS scale, and the need for analgesia before and after the\n      procedure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pregnant patients with a viable singleton\n\n          -  Pregnancy 14-20 weeks of gestation\n\n          -  Admitted for termination of pregnancy\n\n        Exclusion Criteria:\n\n          -  Contraindication for administration of Misoprostol\n\n          -  Patients with more than one previous cesarean section scar\n\n          -  Patients with impaired coagulation\n\n          -  Significant pulmonary or cardiac disease\n\n          -  Non viable pregnancy\n\n          -  Placenta accreta or previa by ultrasound"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01678703", 
            "org_study_id": "2trimabort.CTIL"
        }, 
        "intervention": [
            {
                "arm_group_label": "Laminaria group", 
                "description": "Insertion of Hygroscopic laminarias into the cervical canal for preparation prior to late surgical abortion. The number of laminarias is according to the cervical compliance.", 
                "intervention_name": "Laminaria, MedGyn Products, Inc. USA.", 
                "intervention_type": "Device", 
                "other_name": "laminaria tents"
            }, 
            {
                "arm_group_label": "Misoprostol group", 
                "description": "Cervical preparation with vaginal Misoprostol 600 mcg overnight the day before the abortion", 
                "intervention_name": "Misoprostol", 
                "intervention_type": "Drug", 
                "other_name": "Cytotec"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Misoprostol"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "late abortion", 
            "laminaria", 
            "Misoprostol", 
            "Cervical preparation"
        ], 
        "lastchanged_date": "August 30, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Holon", 
                    "country": "Israel", 
                    "zip": "58100"
                }, 
                "name": "Edith Wolfson Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Controlled Study: Comparison of Laminaria and Misoprostol for Cervical Preparation Before Second Trimester Surgical Abortion", 
        "other_outcome": {
            "description": "The difficulty score will be recorded by the surgeon at the operating room immediately upon completion of the procedure.", 
            "measure": "The degree of difficulty to accomplish the abortion", 
            "safety_issue": "No", 
            "time_frame": "at the time of performing the surgical abortion"
        }, 
        "overall_official": {
            "affiliation": "Tel Aviv University, Sackler Medical School, Israel", 
            "last_name": "Ron Sagiv, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The surgical abortion will be performed 8-12 hours after the insertion of laminaria, or after vaginal application of Misoprostol", 
            "measure": "Initial cervical opening and the need for further dilatation at the start of the procedure", 
            "safety_issue": "Yes", 
            "time_frame": "8-12 hours after insersion of laminaria or Misoprostol"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01678703"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The pain score will be accessed immediately after the insertion of the laminaria or the vaginal Misoprostol.\nPain score will be recorded again right before performing the abortion and will address the 8-12 hours elapsed from the insertion.\nAnother assessment of pain will be recorded immediately after the abortion following recovery from general anesthesia", 
            "measure": "pain score during cervical preparation and after the procedure", 
            "safety_issue": "No", 
            "time_frame": "at the time of the insertion, immediately before the abortion and immediately upon recovery from anesthesia"
        }, 
        "source": "Wolfson Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Wolfson Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }
}